Oral Contraceptive Use Influences On-Kinetic Adaptations to Sprint Interval Training in Recreationally-Active Women
Question
Does oral contraceptive use influence pulmonary, cardiovascular, and muscle oxygenation adaptations to sprint interval training in recreationally active women?
Summary
Recreationally active women completed 4 weeks of supervised cycle sprint interval training. Training improved time to fatigue in both oral-contraceptive users and naturally cycling women, but physiological adaptations differed by hormonal status: VO2 kinetics improved mainly in naturally cycling women, while muscle oxygenation kinetics improved mainly in oral-contraceptive users.
Methodology
- 47 healthy recreationally active women grouped by oral contraceptive use.
- 47 participants.
- Wattbike cycling.
- Work intervals: 1 min.
- Recovery: 2 min passive recovery.
- Intensity: 100-120% peak power output; maximal sustainable effort.
- About 30 min interval block.
- 3 sessions/week.
- 4 weeks.
- Non-randomized comparative intervention grouped by oral contraceptive status
- Time to fatigue, VO2 kinetics, and Muscle oxygenation were tracked.
Outcomes
Time to fatigue
Both groups improved exercise tolerance.
Time to fatigue increased in both groups, p<0.001; no clear between-group difference.
VO2 kinetics
VO2 kinetics improved in naturally cycling women but not oral-contraceptive users.
MC improved at moderate p=0.021 and high p=0.015; group x time moderate p=0.020.
TSI kinetics
Muscle tissue saturation kinetics improved in oral-contraceptive users but not naturally cycling women.
OC improved at moderate and high intensity, both p<0.001; group x time moderate p=0.001, high p<0.001.
Insights
- A 1:2 work-rest cycle SIT format improved performance in active women.
- Adaptation mechanisms may vary by oral contraceptive status.
- Mechanistic physiology findings should not be simplified into one-size-fits-all claims.
Limitations
- Groups were not randomized by contraceptive status.
- Short 4-week intervention.
- Mechanistic outcomes may not map directly to user-facing benefits.
- Safety and adherence reporting was limited.
- Female hormonal subgroup findings limit generalizability.
Safety
- Training was supervised and HR/RPE/power were recorded.
- Adverse events and injuries were not clearly reported.